Mary T. Szela, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 5,962 shares at $53.93 ($322K) on 2010-02-16, disclosed to the SEC on 2010-02-18.
Scheduled sale ($322k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.93 | 600 | $32K | 10.1% |
| 2 | $53.93 | 900 | $49K | 15.1% |
| 3 | $53.93 | 4,462 | $241K | 74.8% |
| Total | $53.93 avg | 5,962 | $322K | 100% |
| Filing → |
| TLSI | SELL | 2026-03-20 | $79K | — | Filing → |
| TLSI | BUY | 2026-02-23 | $125K | — | Filing → |
| TLSI | BUY | 2025-01-31 | $52K | — | Filing → |